Objective: Complementary and alternative medicine (CAM) therapies do not have scientifically proven benefits, are preferred instead of medical therapies, or are used together with them. We investigated the prevalence of CAM use in a serious disorder with a short life expectancy, lung cancer (LC). Material and Methods: This study was planned as a cross-sectional study, and patients diagnosed with LC who applied to our clinic between 2017 and 2018 were invited to the study. 101 patients who accepted the invitation to study and whose consents were obtained were included in the study. Results: The mean age of the patients was 64.25±8.17 (42-82) years, majority of them were male patients (90%), and the prevalence of CAM therapy use was 62.2% (n=56/90). Herbal products were most frequently preferred. It was determined that the patients who were recommended a diet by their doctor used alternative therapies at a lower rate than the patients who have any recommendation (p=0.040). Conclusion: It is important to give a special nutrition program to the patient with LC and to ask the patients whether they use CAM therapies.
Keywords: Lung cancer; nutrition; complementary and alternative medicine; therapy
Amaç: Tamamlayıcı ve alternatif tedavi (TAT), bilimsel olarak kanıtlanmış yararı olmayan, medikal tedavilerin yerine tercih edilen veya birlikte kullanılan uygulamalardır. Akciğer kanseri (AK) gibi yaşam beklentisi düşük, ciddi bir hastalık durumunda TAT kullanımı yaygınlığı araştırıldı. Gereç ve Yöntemler: Bu çalışma kesitsel bir çalışma olarak planlanmış olup, 2017-2018 yılları arasında kliniğimize başvuran AK tanılı hastalar çalışmaya davet edildi. Çalışma davetini kabul eden ve onamları alınan 101 hasta çalışmaya dâhil edildi. Sorular 2 bölümden oluşmakta olup, ilk bölümde, demografik özellikler ve hastalık bilgileri (hücre tipi, ailede kanser hikâyesi olması); ikinci bölümde, doktorun beslenme önerisi, hastanın TAT tercihi (bitkisel, hayvansal, diğer), tercih nedenleri, olumlu etki yönü, doktoruna bilgi verme, ailede kanser hikâyesinin tercihe etkisi bilgileri kayıt edildi. Bulgular: Hastaların yaş ortalaması 64,25±8,17 (42-82) yıl ve erkek hasta sayısı (%90) daha ağırlıklı olup TAT kullanımı (n=56/90) yaygınlığı %62,2 saptandı. Sıklıkla tercih edilen ürünlerin bitkisel kaynaklı olduğu izlendi. Doktor tarafından beslenme şekli önerilen hastaların, öneride bulunulmayan hastalara göre daha az oranda alternatif tedavi kullandığı saptandı (p=0,040). Sonuç: AK tanılı hastaya özel beslenme programı verilmesi ve hastalara TAT kullanıp kullanmadığının sorulması önem arz eder.
Anahtar Kelimeler: Akciğer kanseri; beslenme; tamamlayıcı ve alternatif tedavi; terapi
- National Health Service [Internet]. [Cited: March 22, 2020]. Complementary and alternative medicine 2018. Available from: [Link]
- Ades T, Yarbro HC. Alternative and complementary therapies in cancer management. In: Yarbro HC, Frogge MH, Goodman M, eds. Cancer Nursing Principles and Practice. 5th ed. Burlington, MA: Jones & Bartlett Learning; 2000. p.617-28.
- National Center for Complementary and Integrative Health [Internet]. [Cited: June 10, 2008]. Complementary, Alternative, or Integrative Health: What's In a Name? Available from: [Link]
- Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: a systematic review. Complement Ther Clin Pract. 2019;35:33-47. [Crossref] [PubMed]
- National Cancer Institute [Internet]. [Cited: January 15, 2019]. Complementary and alternative medicine. Available from: [Link]
- Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, et al. The Trials (and Tribulations) of complementary and alternative medicine in oncology. J Natl Cancer Inst. 2019;111(12):1358-60. [Crossref] [PubMed] [PMC]
- Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187-203. [Crossref] [PubMed]
- Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health. 2002;92(10):1582-91. [Crossref] [PubMed] [PMC]
- Molassiotis A, Fernández-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655-63. [Crossref] [PubMed]
- Kav S, Hanoğlu Z, Algıer L. Türkiyede kanserli hastalarda tamamlayıcı ve alternatif tedavi yöntemlerinin kullanımı: literatür taraması [Use of complementary and alternative medicine by cancer patients in Turkey: a literature review]. Uluslararası Hematoloji-Onkoloji Dergisi. 2008;18(1):32-8. [Link]
- Yılmaz Ü. Akciğer Kanserlerinde Tedavi Yaklaşımları. Nucl Med Semin. 2018;4:32-8. [Crossref]
- Mansky PJ, Wallerstedt DB. Complementary medicine in palliative care and cancer symptom management. Cancer J. 2006;12(5):425-31. [Crossref] [PubMed]
- Adams M, Jewell AP. The use of Complementary and Alternative Medicine by cancer patients. Int Semin Surg Oncol. 2007;4:10. [Crossref] [PubMed] [PMC]
- Tas F, Ustuner Z, Can G, Eralp Y, Camlica H, Basaran M, et al. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients. Acta Oncol. 2005;44(2):161-7. [Crossref] [PubMed]
- Ceylan S, Hamzaoğlu O, Kömürcü S, Beyan C, Yalçin A. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med. 2002;10(2):94-9. [Crossref] [PubMed]
- Shumay DM, Maskarinec G, Kakai H, Gotay CC; Cancer Research Center of Hawaii. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract. 2001;50(12):1067. [PubMed]
- Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology. 2002;11(3):212-20. [Crossref] [PubMed]
- Gözüm S, Arikan D, Büyükavci M. Complementary and alternative medicine use in pediatric oncology patients in eastern Turkey. Cancer Nurs. 2007;30(1):38-44. [Crossref] [PubMed]
- Tovey P, Broom A. Oncologists' and specialist cancer nurses' approaches to complementary and alternative medicine and their impact on patient action. Soc Sci Med. 2007;64(12):2550-64. [Crossref] [PubMed]
- Akyürek S, Önal C, Kurtman C. Akciğer kanserli hastalarda alternatif tedavi kullanımı [Use of alternative medicine in patients with lung cancer]. Türk Hematoloji-Onkoloji Dergisi. 2005;15(2):73-7. [Link]
- Mazicioglu MM, Serin MS, Sahan H. Attitude of patients with gynaecologic malignancies in selecting alternative and complementary therapies. Middle East Journal of Family Medicine. 2006;14:12-5. [Link]
- Özçelik H, Fadıloğlu Ç. Kanser hastalarının tamamlayıcı ve alternatif tedavi kullanım nedenleri [Reasons for use of complementary and alternative medicine in cancer patients]. Türk Onkoloji Dergisi. 2009;24(1):48-52. [Link]
- American Cancer Society [Internet]. [Cited: March 22, 2020]. The Truth About Alternative Medical Treatments 2019. Available from: [Link]
- Gorski DH. Cancer quackery and fake news: targeting the most vulnerable In: Bernicker EH, ed. Cancer and Society: A Multidisciplinary Assessment and Strategies for Action. 1st ed. Cham: Springer International Publishing; 2019. p.95-112. [Crossref]
- Braun L, Harris J, Katris P, Cain M, Dhillon H, Koczwara B, et al. Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients. Asia Pac J Clin Oncol. 2014;10(4):289-96. [Crossref] [PubMed]
- Australian Government National Health and Medical Research Council [Internet]. [Cited: January 16, 2019]. Talking with your patients about complementary medicine-a resource for clinicians. Available from: [Link]
- Erbaycu AE, Gülpek M, Tuksavul F, Uslu Ö, Güçlü SZ. Akciğer kanserinde çeşitli bitkisel ve diğer karışımların kullanımına sosyo-demografik ve tümöre bağlı faktörlerin etkisi (akciğer kanserinde tamamlayıcı tedavi kullanımı) [Effect of socio-demographic and tumor related factors on use of various herbal and other mixtures in lung cancer (use of complementary treatment in lung cancer)]. Turk Toraks Dergisi. 2010;11(3):117-20. [Crossref]
- Kristoffersen AE, Norheim AJ, Fønnebø VM. Complementary and alternative medicine use among norwegian cancer survivors: gender-specific prevalence and associations for use. Evid Based Complement Alternat Med. 2013;2013:318781. [Crossref] [PubMed] [PMC]
- Kuo YT, Chang TT, Muo CH, Wu MY, Sun MF, Yeh CC, et al. Use of complementary traditional chinese medicines by adult cancer patients in taiwan: a nationwide population-based study. Integr Cancer Ther. 2018;17(2):531-41. [Crossref] [PubMed] [PMC]
- Kufel-Grabowska J, Bartoszkiewicz M, Litwiniuk M. The use of complementary and alternative medicine among cancer patients. Polish Archives of Internal Medicine. 2021;131(1):83-5. [Crossref]
- Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, et al. Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients. Eur J Cancer. 2017;71:70-9. [Crossref] [PubMed]
- Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A, et al. Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey. Oncotarget. 2017;8(15):24401-14. [Crossref] [PubMed] [PMC]
- Shahmoradi N, Kandiah M, Peng LS. Impact of nutritional status on the quality of life of advanced cancer patients in hospice home care. Asian Pac J Cancer Prev. 2009;10(6):1003-09. [PubMed]
- Paccagnella A, Morassutti I, Rosti G. Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol. 2011;23(4):322-30. [Crossref] [PubMed]
- Kämmerer U, Klement RJ, Joos FT, Sütterlin M, Reuss-Borst M. Low carb and ketogenic diets ıncrease quality of life, physical performance, body composition, and metabolic health of women with breast cancer. Nutrients. 2021;13(3):1029. [Crossref] [PubMed] [PMC]
.: İşlem Listesi